During the past decade, Edward Hospital/Cancer Center conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 50 clinical trials were completed, i.e. on average, 102% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 20 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Edward Hospital/Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "SWOG Cancer Research Network" with 24 trials sponsored, "NSABP Foundation Inc" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Edward Hospital/Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NSABP Foundation Inc" with 6 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Edward Hospital/Cancer Center" are "Breast Cancer" (22 trials), "Lung Cancer" (5 trials), "Lymphoma" (5 trials), "Recurrent Breast Carcinoma" (5 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (5 trials). Many other conditions were trialed in "Edward Hospital/Cancer Center" in a lesser frequency.

Most popular intervention types in "Edward Hospital/Cancer Center" are "Drug" (96 trials), "Other" (58 trials), "Biological" (34 trials), "Radiation" (32 trials) and "Procedure" (24 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (26 trials), "Laboratory Biomarker Analysis" (24 trials), "Placebo" (13 trials), "Radiation Therapy" (12 trials) and "Computed Tomography" (11 trials). Other intervention names were less common.

The vast majority of trials in "Edward Hospital/Cancer Center" are 83 trials for "All" genders, 27 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Edward Hospital/Cancer Center". undefined are not yet recruiting, 20 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Edward Hospital/Cancer Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Edward Hospital/Cancer Center, 2 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".